A Study of SEP-380135 in Adults With Schizophrenia or Major Depressive Episode

Clinical trial NCT07549581 · COMPLETED

Trial details

NCT number: NCT07549581
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Schizophrenia Major Depressive Disorder (MDD)Bipolar Disorder

Start date: 2024-11-07
Primary completion: 2025-09-12
Enrollment: 43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.